July 2018 Find out more about: Getting to Know CEO Chris Ilsley Member Spotlight – Glycologix Five Words – Our Companies Do What? Around the World with NSIV Read the newsletter in your browser or open it as a PDF.Read more
July 2018 Find out more about: Getting to Know CEO Chris Ilsley Member Spotlight – Glycologix Five Words – Our Companies Do What? Around the World with NSIV Read the newsletter in your browser or open it as a PDF.Read more
New NSIV CEO & President, Chris Ilsley (say “ills lee”) has been with us for just over a month. We briefly introduced him to you in last month’s newsletter, but now it’s time for a bit more in-depth look. To help us get acquainted, he recently sat down for a Q&A. Find out about hisRead more
This month, we welcome back Glycologix, who recently rejoined NSIV. At Glycologix, what began as a potential cure for wrinkles has evolved into what could become the first treatment on the market for a debilitating urology disease. The company is developing a compound that mimics the properties of proteogylcans, molecules which provide hydration and performRead more
NSIV member company, InsomniSolv, recently won Sanofi’s VivaTech 2018 “Sleep Challenge”, voted the winner over 21 other submissions. Founder, Peter Kelley, is developing a neurostimulator device to mitigate insomnia. Read about the “Sleep Challenge” and watch a short video about InsomniSolv here.Read more
June 2018 Find out more about: Welcome to New NSIV President & CEO Member Spotlight – Genomic Expression New Companies Join NSIV Summer Interns are Here! The World Cup Read the newsletter in your browser or open it as a PDF.Read more
On June 18, 2018, the North Shore InnoVentures board announced the appointment of Chris Ilsley as CEO and President. Ilsley replaces outgoing CEO Martha Farmer who has overseen a decade of growth for the biotech and cleantech Incubator. North Shore InnoVentures (NSIV) is a non-profit technology business incubator helping biotech and cleantech startups increase their probability ofRead more
Every year, $100 billion goes into standard cancer treatment, prescribed based on the cancer’s stage and tissue of origin. Patients receiving these treatments assume that they are being given the medicine they need, but the reality is inauspicious — every cancer is unique, and only 1 out of 4 standard treatments will actually prolong life.Read more
May 2018 Find out more about: NSIV is turning 10! Cummings Foundation Awards Ceremony Member Spotlight – CrowdComfort NSIV Spring ’18 Interns Newest Lab Equipment Read the newsletter in your browser or open it as a PDF.Read more
CrowdComfort CrowdComfort started as a simple idea, pitched at the 2013 Boston Cleanweb Hackathon: what if people could use their smartphones to unlock efficiencies in building and workplace management? Since these humble beginnings, CrowdComfort has come a long way. With the help of Boston’s wonderful cleantech community, it launched the world’s first Human Sensor Network™Read more
April 2018 Find out more about: NSIV Wins Technology Incubator of the Year NSIV Awarded 10-Year Sustaining Grant from Cummings Foundation Member Spotlight – Akita Innovations Sad News from NSIV Headquarters Read the newsletter in your browser or open it as a PDF.Read more
Interested in incubating your company with InnoVenture Labs? Submit your application today!